"10.1371_journal.pone.0126704","plos one","2015-05-11T00:00:00Z","Shuyan Gu; Jihao Shi; Zhiliu Tang; Monika Sawhney; Huimei Hu; Lizheng Shi; Vivian Fonseca; Hengjin Dong","Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China; Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China; Health Economics and Outcome Research (HEOR), Bristol-Myers Squibb, Shanghai City, China; College of Health Professions, Marshall University, Huntington, West Virginia, United States of America; Department of Global Health Systems and Development, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, United States of America; Section of Endocrinology, Department of Medicine, School of Medicine, Tulane University, New Orleans, Louisiana, United States of America","Conceived and designed the experiments: SG HD. Performed the experiments: SG JS HH HD. Analyzed the data: SG JS HH. Contributed reagents/materials/analysis tools: SG JS ZT HD. Wrote the paper: SG MS LS VF HD.","The authors have the following interests. This study was funded by Bristol-Myers Squibb, the employer of Zhiliu Tang and producer of Metformin. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","05","Shuyan Gu","SG",8,TRUE,2,4,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
